GVK Biosciences, an India-based research services provider, has entered into a strategic alliance with Excel PharmaStudies, a Chinese CRO, to conduct clinical trials in Asia. Through the alliance sponsors will be able to conduct Phase II-IV trials taking advantage of India’s experience with Phase II/III trials and China’s large market, and Phase III/IV studies. Under the terms of the agreement, GVK BIO and Excel will help sponsors conduct and manage Phase II-IV trials, statistical...